PMS29 Cost Effectiveness of Adalimumab Versus Golimumab and Placebo in Ankylosing Spondylitis in Italy
Nov 1, 2012, 00:00 AM
10.1016/j.jval.2012.08.1384
https://www.valueinhealthjournal.com/article/S1098-3015(12)03097-5/fulltext
Section Title :
Muscular-Skeletal Disorders
Section Order :
881
First Page :
A444
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)03097-5&doi=10.1016/j.jval.2012.08.1384